NorthWest Biotherapeutics Inc (NWBO)

[dmb2]

I am hopeful there will be a comprehensive platform development strategy and plan unveiled once TLD is published. I am also hopeful it includes a development partner who will also be the commercialization partner. If results are strong competition will be fierce due to the relatively low IP hurdles with a therapy such as this. Indication expanding and therapy expanding trials will become easier and shorter but in order to maintain a development lead this technology will play a role. Preparing to develop the platform would include procuring and protecting the required technology as much as possible. Sorting through the combination options prior to TLD publication is important so the development plan is formed.

It is(almost) time to shift from hope for results to hope for market leadership company growth plans.

GLTA